Text Size





Managing Afib Virtual Grand Rounds banner

Managing Atrial Fibrillation
to Prevent Stroke

A Virtual Grand Rounds Activity

For informational purposes only. Accreditation for this program has expired.

View complete overview and accreditation requirements

Program Overview
Atrial fibrillation (AFib) affects more than 2 million people in the U.S. and is a serious risk factor for stroke. Despite evidence-based guidelines for managing AFib and estimates that two-thirds of AFib-related strokes can be avoided, serious gaps continue to exist between clinical knowledge and practice, leaving patients at risk for disabling strokes.

The Managing Atrial Fibrillation to Prevent Stroke virtual grand rounds addresses AFib and how it is diagnosed and treated; reviews prevalence of stroke in AFib patients; discusses the use of appropriate tools to assess stroke risk; promotes the use of current guidelines‐based strategies for managing AFib for patients at different levels of stroke risk; shares strategies for discussing AFib and stroke risk more effectively with patients; and evaluates the emerging agents for stroke prevention in AFib.

Goals and Learning Objectives
The goal of the Managing Atrial Fibrillation to Prevent Stroke virtual grand rounds is to improve the diagnosis and treatment of AFib to prevent stroke by educating participants on the most current treatment guidelines and clinical research. Upon completion of this activity, participants will be able to:

  • Recognize the signs and symptoms of AFib, such as abnormal rhythm, rate and/or near syncope as described by the patient or caregiver using nonmedical vernacular.
  • Select the appropriate diagnostic test(s) for the initial diagnosis of AFib to determine underlying causes and severity of AFib and to monitor improvement after AFib treatment.
  • Demonstrate an understanding of the AFib guidelines with regard to stroke risk.
  • Communicate essential information regarding AFib and stroke risk to the patient.
  • Assess the risk of stroke in patients with AFib by correctly calculating a CHADS2 risk score.
  • Determine appropriate anticoagulation based upon the stroke risk calculation, clinical guidelines and new scientific evidence.
  • Determine appropriate rhythm management and rate control strategies based upon clinical guidelines and new scientific evidence.
  • Distinguish which AFib patients should be referred to a specialist.
  • Manage patients who have undergone an ablation procedure.

Target Audience
The target audience for the Managing Atrial Fibrillation to Prevent Stroke virtual grand rounds includes primary care clinicians and cardiologists practicing in and near stroke center hospitals, as well as hospital-based physicians, nurses and other healthcare professionals treating AFib among at-risk populations.

Content Developed by
Philip B. Gorelick, MD, MPH, FACP

Medical Director
Hauenstein Neuroscience Institute
Grand Rapids, Michigan

Jonathan L. Halperin, MD

Robert and Harriet Heilbrunn Professor of Medicine
Mount Sinai School of Medicine
Director of Clinical Cardiology Services
Zena and Michael A. Wiener Cardiovascular Institute
The Mount Sinai Medical Center
New York, New York

Disclosure of Faculty’s Commercial Relationship(s)

It is the policy of the Heart Rhythm Society to ensure balance, independent objectivity and scientific rigor in all its certified educational activities. Everyone involved in the planning and participation of continuing medical education activities is required to disclose any real or apparent conflict of interest related to the content of their presentations and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations. In accordance with the ACCME's Standards for Commercial Support for continuing medical education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The Heart Rhythm Society implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners. Detailed disclosure information will be available prior to the activity and in the activity slides.

View complete overview and accreditation requirementsThe original program was recorded on June 11, 2012.
For informational purposes only. Accreditation for this program has expired.

For questions reguarding this program, contact Valerie Siebert-Thomas at vsiebert-thomas@stroke.org.

This activity is supported by educational grants from the following companies:
Ortho-McNeil, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC and Bristol-Myers Squibb and Pfizer, Inc.

Get Involved

Stroke and You

National Stroke Association

9707 E. Easter Lane, Suite B
Centennial, CO 80112